Concord Drugs Ltd | Scrip Code : 538965 | Quarter ending :September 2017 |
| Declaration
| |
|
|
Whether the Listed Entity has issued any partly paid up shares? | No | Whether the Listed Entity has issued any Convertible Securities ? | No | Whether the Listed Entity has issued any Warrants ? | No | Whether the Listed Entity has any shares against which depository receipts are issued? | No | Whether the Listed Entity has any shares in locked-in? | Yes | Whether any shares held by promoters are pledge or otherwise encumbered? | No | Whether company has equity shares with differential voting rights? | No |
| Summary statement holding of specified securities
| |
|
|
(A) Promoter & Promoter Group | 5 | 28,40,500 | 28,40,500 | 39.21 | 28,40,500 | 39.21 | 16,38,600 | 57.69 | 28,40,500 | - | - | - | (B) Public | 1,722 | 44,03,250 | 44,03,250 | 60.79 | 44,03,250 | 60.79 | | 0.00 | 36,26,450 | - | - | - | (C1) Shares underlying DRs | | | | 0.00 | | 0.00 | | 0.00 | | - | - | - | (C2) Shares held by Employee Trust | | | | 0.00 | | 0.00 | | 0.00 | | - | - | - | (C) Non Promoter-Non Public | | | | 0.00 | | 0.00 | | 0.00 | | - | - | - | Grand Total | 1,727 | 72,43,750 | 72,43,750 | 100.00 | 72,43,750 | 100.00 | 16,38,600 | 22.62 | 64,66,950 | - | - | - |
| Note:C=C1+C2 Grand Total=A+B+C
|